In the context of HCC, FGF19, the ligand for FGFR4, is frequently amplified and overexpressed, leading to the activation of the FGFR4 signalling pathway and contributing to tumour development and progression.71 The gene discussed is FGF19; the disease is hepatocellular carcinoma.